Глицин форте

Quick links

Choose a section

Quick links to important sections

Advertisements

Глицин форте

Advertisements
Advertisements
Advertisements

Overview of Глицин форте

What is Glycine Forte?

Property Description
Active ingredient Glycine (Aminoacetic acid)
Form Oral tablets (typically high-dose)
Pharmacological class Metabolic Agent; Glycine Agent
Common use Nervous system regulation; stress management
Origin Non-essential amino acid (naturally occurring)

Glycine Forte: Identity and Composition

Glycine Forte is a specific over-the-counter (OTC) preparation and dietary supplement containing an enhanced concentration of the active ingredient, the amino acid Glycine. The descriptor Forte signifies a high-dose formulation compared to standard Glycine supplements, typically presented in the form of oral tablets.

The core compound, Glycine (Aminoacetic acid), is recognized as the simplest proteinogenic amino acid and is fundamentally classified as a non-essential amino acid, meaning the human body can synthesize it for use in protein and antioxidant production. As a single active ingredient product, its composition is focused on augmenting the body's natural supply of this compound.

Pharmacological Class and General Purpose

Glycine Forte is classified as a Metabolic Agent but is primarily known functionally as a Neurotransmitter agent. It operates as the major inhibitory neurotransmitter in the spinal cord and brainstem, a function clinically recognized for its role in promoting neuromuscular relaxation and reducing nerve hyper-excitability.

The preparation’s general therapeutic purpose is to support the nervous system’s innate capacity for self-regulation. By bolstering the supply of this key inhibitory agent, Glycine Forte is typically utilized to help the body manage emotional stress and alleviate nervous tension, contributing to a more balanced state of cognitive support and overall mental equilibrium.

Advertisements

What side effects are possible with Глицин форте?

Possible Side Effects and Safety Information

The safety profile for orally administered Glycine (the active ingredient in Glycine Forte) is characterized by a low incidence of adverse reactions, which are typically mild and infrequent when documented in regulatory summaries.


Documented Adverse Reactions

Adverse effects are generally not formally classified using standard frequency categories (such as 'Common' or 'Uncommon') in available product safety summaries. However, documented effects primarily involve two system-organ classes:

  • Gastrointestinal Disorders: These may include stomach upset, nausea, or diarrhea.
  • Nervous System Disorders: Documented effects include mild sedation and drowsiness.

Serious Adverse Reactions and Restrictions

While highly uncommon, the most significant documented adverse event is the potential for Hypersensitivity or Allergic Reactions. Symptoms such as rash, itching, or difficulty breathing represent the highest level of adverse event concern and require attention.

Safety is formally restricted in several contexts:

  • Contraindication: Use is restricted in individuals with a known allergy or hypersensitivity to Glycine or any components of the preparation.
  • Pregnancy and Breastfeeding: Safety has not been established due to a lack of reliable data, and avoidance is generally advised.
  • Drug Interaction: Concomitant use with the specific antipsychotic drug clozapine (Clozaril) is advised against, as Glycine may decrease the effectiveness of that medication, a safety constraint documented in official interaction profiles.

The safety documentation notes that research into the effects of long-term supplementation is not extensive. Use should be approached with caution in individuals with pre-existing liver conditions.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for overdose with Glycine (Aminoacetic acid) is characterized by the mandatory requirement for immediate emergency action. Due to its nature as a simple, non-essential amino acid, regulatory documents typically do not list a specific spectrum of clinical signs or severe physiological outcomes universally associated with the ingestion of excessive oral doses. The focus of the regulatory labels is on the proper course of action following overexposure.

When to Seek Urgent Medical Attention

Regulatory authorities explicitly state that immediate medical help must be sought right away following any instance of acute ingestion beyond the recommended amount. The mandated action is to contact a physician or Poison Control Center immediately. This instruction defines the threshold for necessary intervention, regardless of whether specific symptoms are immediately apparent. As a mandatory regulatory precaution, the product is required to be kept out of the reach of children.

Management and Monitoring

Management of excessive ingestion is officially guided as symptomatic and supportive treatment. Official regulatory statements indicate that no specific antidote is known or listed for Glycine overdose. Following the mandate to seek emergency services, hospital monitoring and observation may be required to manage any adverse effects that may arise.

Advertisements

Therapeutic Uses of Глицин форте

What Glycine Forte Treats: Main Uses and Benefits

Glycine Forte is commonly used to help with symptoms related to heightened physiological activity, applied across domains where additional symptomatic support is needed. It is considered relevant for easing nervous tension, emotional stress, and subjective sleep complaints, which often cluster with mental exhaustion and poor concentration.

The preparation is applied in scenarios where symptoms intensify and supportive relief is needed, such as during periods of high mental or emotional load or following acute sleep restriction. Glycine may play a role in managing these symptoms. The therapeutic benefit is primarily focused on easing the overall symptom burden and helping patients cope more steadily with daily fluctuations.

“This supportive agent may assist with maintaining a sense of stability when symptoms become more noticeable, offering symptomatic relief that contributes to improved comfort during difficult episodes.”

This supportive use is relevant in conditions characterized by episodic or fluctuating manifestations that interfere with functional stability.


Summary of Therapeutic Support

The preparation is commonly used to help with difficulty falling asleep and stress-related cognitive fatigue, supporting better daytime alertness and mental equilibrium.

Regulatory References

  1. NIH PubMed Central study on Glycine
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Глицин форте?

The population eligibility for Глицин форте is strictly defined by regulatory documentation, based on safety data and the product's high-dose formulation. The medicine is primarily intended for Adults (18 years and older) and Adolescents (Aged 12 years and older).


Absolute Contraindications

Use is strictly contraindicated and must be avoided in the following groups:

  • Patients with documented hypersensitivity or individual intolerance to Glycine or any components of the formulation.
  • Children under 12 years of age, due to the high-dose nature of the Forte preparation and insufficient pediatric safety data.
  • Patients with severe renal dysfunction, such as anuria, due to metabolic considerations for high doses.

Restricted and Non-Recommended Use

Certain populations should only use the product under specific conditions or are formally advised against use:

  • Pregnancy and Lactation: Use during pregnancy and breastfeeding is formally not recommended by regulators because insufficient clinical data exists to establish safety in these states.
  • Comorbidity: The medicine is contraindicated in patients concurrently receiving treatment with the antipsychotic Clozapine, as Glycine may reduce the drug's therapeutic effect.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for Glycine Forte focuses predominantly on pharmacodynamic interactions rather than metabolic (pharmacokinetic) effects, consistent with its status as an amino acid agent.

Pharmacodynamic Reinforcement

Glycine, acting as an inhibitory neurotransmitter, carries a caution regarding co-administration with other substances that cause Central Nervous System (CNS) depression. This is classified in regulatory materials as a use-with-caution combination due to the potential for an additive or potentiating increase in sedation or drowsiness.

Interacting Product Categories:

  • Medicinal Products: Includes broad categories such as anxiolytics, sedatives, hypnotics, and anticonvulsants.
  • Substances and Supplements: This additive effect extends to alcohol and certain herbal or dietary supplements known for possessing sedative or calming properties (e.g., Valerian root).

The regulatory documentation does not specify any formal contraindications for co-administration. Furthermore, official labels typically do not contain specific warnings regarding metabolic enzyme interactions, such as Cytochrome P450 (CYP) inhibition or induction, nor do they list interactions mediated by major drug transporters (e.g., P-gp). No mandatory timing-based separation rules or population-specific interaction constraints related to hepatic or renal status are documented in official prescribing information.

Advertisements

Mechanism of Action

Direct Enhancement of Central Inhibition

The molecule's primary action is to function as a direct agonist at the Glycine Receptor ( GlyR), a ligand-gated chloride ion ( Cl^-) channel predominantly located in the spinal cord and brainstem. Activation of this receptor triggers a rapid postsynaptic hyperpolarization, which dampens the excitability of nerve cells. This mechanism is central to the modulation of motor reflex circuits and the regulation of basal neuronal tone by limiting action potential generation.

Modulatory Role in Excitatory Pathways

Glycine also interacts with the N-methyl- D-aspartate Receptor ( NMDAR), a key mediator of excitatory signaling, by acting as an obligatory co-agonist at its dedicated binding site. This modulatory action facilitates NMDAR-dependent physiological functions and works in conjunction with the inhibitory mechanism to modulate the Excitatory/Inhibitory ( E/I) balance within the central nervous system.

Mechanistic Constraints and Saturation

The mechanism is constrained by the existing high endogenous concentration of Glycine, which establishes a physiological limit on GlyR target activity. Furthermore, the NMDAR modulatory effect is entirely dependent on the simultaneous presence and binding of the main agonist, Glutamate, functionally limiting the scope of this secondary action.

Advertisements

Dosage and Administration Information

How to Use Glycine Forte

This section describes the administration and dosage patterns for high-dose Glycine (Aminoacetic acid) preparations, based on standardized procedural documentation and clinical models.


Administration Details

The preparation is intended exclusively for oral ingestion, typically in the form of a high-dose tablet or equivalent concentration for dissolution. The dosing schedule is established for both general daily support and targeted functional use.

  • Standard Regimen: The typical daily intake for adults ranges from 3 to 5 grams of Glycine.
  • Targeted Use: For focused support, such as before sleep, a dose of 3 grams is administered.
  • Maximal Use: Doses up to 6 grams per day have been employed in short-term clinical protocols to assess tolerability and efficacy.

Administration is structured to be either once daily or in divided doses throughout the day when the total daily intake is higher than the standard regimen. The total dose is often divided to support better gastrointestinal tolerance.

Contextual Timing and Duration

The timing of the dose is linked to the administration goal. For targeted functional support, the dose is taken immediately before bedtime. For general daily use, the dose may be administered with meals.

The use of high-dose Glycine is typically prescribed in short-term, defined courses, with procedural documentation generally supporting periods of administration ranging from 4 to 24 weeks. The duration emphasizes intermittent use aligned with periods of perceived need rather than continuous long-term therapy.

  • Population Adjustments: No universally mandated dose adjustments for older adults or patients with renal or hepatic impairment are explicitly provided for high-dose oral Glycine.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Глицин форте


Research Examining Outcomes Related to Sleep and Daytime Function

Research on Glycine primarily involves short-term, randomized controlled trials (RCTs) applied in healthy adults or subjects under sleep restriction. Studies examine self-reported sleep quality, time taken to fall asleep (latency), and subsequent subjective feelings of daytime fatigue. While studies describe patterns observed in the subjective data, findings were mixed when researchers assessed objective physiological sleep markers. The evidence is currently limited to short-term observation periods.

Research Examining Cognitive and Mental Function Outcomes

Glycine was studied for cognitive function, including memory and attention, often as a secondary outcome in trials focused on fatigue or sleep. The overall findings were mixed; while some studies reported observations related to psychomotor function, data on memory varied across trials. What remains uncertain is the extent to which any observed effect is independent of Glycine’s potential influence on rest.

Research Examining Metabolic and Cardiovascular Outcomes

This evidence is drawn from small-scale interventional studies and observational research exploring outcomes related to systemic imbalance, such as glucose regulation and blood pressure. Observational findings indicate that low plasma glycine was associated with higher physiological markers for conditions like Type 2 Diabetes. However, interventional trials often used very high doses, and the evidence remains primarily associative, not establishing a definitive causal effect from supplementation.

Key Evidence Gaps and Areas of Uncertainty

The overall evidence quality varies across studies, with a consistent limitation being modest sample sizes in many interventional trials. There is limited information for long-term outcomes and the durability of response. Dedicated research in special populations (e.g., children or pregnancy-related groups) is insufficient, and comparative evidence against other interventions is lacking.

Key Studies & References

  1. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Глицин форте (FAQ)


Q: What is the main difference between Глицин форте and regular glycine supplements?

A: The term 'Forte' is used to signify that this preparation contains an enhanced concentration of the active ingredient, glycine (aminoacetic acid), compared to basic or standard dietary supplements. Official product information describes it as a high-dose formulation.


Q: Is it normal to feel a little drowsy when first taking Глицин форте?

A: Official safety summaries document that mild effects on the nervous system, such as drowsiness and sedation, are known possible effects. These are among the mild adverse reactions reported in the product safety profile.


Q: What is the maximum duration of use mentioned in official guidelines for Глицин форте?

A: Regulatory procedural documentation for this type of high-dose Glycine preparation generally supports administration for periods ranging from 4 to 24 weeks. The duration of use documentation describes intermittent application rather than continuous long-term therapy.


Q: Can older adults (seniors) safely use Глицин форте?

A: The preparation is intended for adults (18 years and older). While official regulatory summaries do not explicitly mandate dose adjustments for older adults, official guidance for older adults aligns with the established eligibility for the adult population.


Q: What are the risks of using Глицин форте if I have pre-existing conditions?

A: Use is strictly contraindicated in patients with severe renal dysfunction. This restriction is based on metabolic considerations for severe renal dysfunction. Official safety documentation also advises caution for individuals with pre-existing liver conditions.


Q: Can Глицин форте be taken on an empty stomach?

A: Official guidance on administration states that for general daily use, the dose may be taken with meals. Official documentation does not provide explicit instruction regarding intake on an empty stomach.


Q: Does Глицин форте interact with common pain relievers like ibuprofen?

A: Official product labeling does not document specific metabolic or enzymatic interactions with common, non-sedating pain relievers such as ibuprofen. The focus of the documented interaction profile is predominantly on substances that cause Central Nervous System (CNS) depression.


Q: Does Глицин форте have a known interaction with oral contraceptives?

A: Official product labeling does not contain specific warnings regarding metabolic enzyme interactions, which would typically cover substances like oral contraceptives.


Q: I'm using B vitamins; is it safe to take Глицин форте at the same time?

A: Official labeling does not specify any formal interactions or restrictions related to concurrent use with B-vitamins or similar non-sedating dietary supplements.


Q: Does Глицин форте need to be cycled (taken for a period, then stopped)?

A: The procedural documentation for this preparation emphasizes intermittent use that is aligned with periods of perceived need. Official documentation does not establish protocols for continuous long-term therapy.


Q: Why do people take Глицин форте for anxiety or stress?

A: The general therapeutic purpose is described as supporting the nervous system's capacity for self-regulation by augmenting the supply of an inhibitory neurotransmitter. It is generally utilized to help the body manage emotional stress and alleviate nervous tension.


Q: Can Глицин форте be used to help with sleep issues?

A: Research has primarily examined the active ingredient in short-term trials for outcomes related to self-reported sleep quality, time taken to fall asleep (latency), and subsequent subjective feelings of daytime fatigue. The product information indicates that research has been conducted in this area.


Q: Does taking Глицин форте affect the liver or kidneys?

A: Use is strictly contraindicated in patients with severe renal dysfunction. This restriction is based on metabolic considerations for severe renal dysfunction. Official safety documentation also advises caution for individuals with pre-existing liver conditions.


Q: Are there any major diet restrictions when using Глицин форте?

A: Official labeling and regulatory summaries for this preparation do not specify any major diet restrictions. The documentation does not list any mandatory separation rules related to the timing of the dose with food intake.


Q: What kind of studies have been done on the effects of Глицин форте?

A: The available research evidence involves studies examining outcomes related to three main areas: sleep and daytime function, cognitive and mental function (like attention and memory), and metabolic and cardiovascular outcomes (like glucose regulation).


Q: Can Глицин форте cause changes in mood or energy levels?

A: Documented adverse reactions in the nervous system primarily include mild sedation and drowsiness. Official information does not specify changes in mood or energy levels beyond these documented effects.


Q: Why is Глицин форте sometimes referred to as a nootropic?

A: The preparation is functionally classified as a Neurotransmitter agent. Furthermore, research has been conducted examining its potential outcomes related to cognitive and mental function, which is consistent with why it is discussed in that context.


Q: Is it true that Глицин форте helps with focus and concentration?

A: Studies have examined the effect of the active ingredient on cognitive functions, including attention (focus). However, official information describes the research findings as mixed, and the overall evidence base is not definitive based on the varied findings.


Q: Can Глицин форте be safely combined with herbal supplements?

A: Co-administration with certain herbal or dietary supplements known to have sedative or calming properties (e.g., Valerian root) is formally classified as a use-with-caution combination. This is due to the potential for an additive increase in sedation or drowsiness.


Q: What are the regulatory classifications of Глицин форте?

A: Official information classifies this preparation as an over-the-counter (OTC) preparation and a dietary supplement. Functionally, it is categorized as a Metabolic Agent and is recognized for acting as a Neurotransmitter agent.


Q: Does Глицин форте help with memory performance?

A: The active ingredient has been examined in studies for its potential role in cognitive functions, including memory. However, the official summary of research indicates that the data varied across trials, and the overall research findings contained varied data.


Q: What is the difference in purpose between Глицин форте and common sedatives?

A: The preparation is functionally classified as an inhibitory neurotransmitter agent and is utilized to support the body’s self-regulation for nervous tension. In contrast, common sedatives belong to different pharmacological classes, such as anxiolytics or hypnotics, which are noted for their potential for additive sedation when used with this preparation.

Advertisements

How should Глицин форте be stored and disposed of?

How to Store and Dispose of Glycine Forte

The official storage and handling requirements for Glycine Forte tablets are defined strictly by regulatory labeling to ensure product stability and safety.

Storage Requirements

The product must be kept at a temperature not exceeding +25 C (77 F). Storage must occur in a dry place and be protected from light.

Storage Component Requirement
Temperature Limit Max +25 C
Packaging Keep in original container
Child Safety Keep out of the sight and reach of children
Stability Do not use after the expiration date

Disposal

Any unused or expired tablets must be disposed of according to local regulations for pharmaceutical waste. The medicine should not be discarded into household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Глицин форте found in:

A-Z Index: